Low-grade inflammation may be one underlying mechanism of metabolic disease, and C-reactive protein (CRP) is an acute-phase protein whose elevated circulating level has been associated with poor glycaemic control(192,193), development of T2D(194,195) and mortality in T2D(196). The gene discussed is CRP; the disease is metabolic disease.